Detalhe da pesquisa
1.
Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemia.
Blood
; 122(5): 734-7, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23801633
2.
Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax.
Clin Cancer Res
; 30(3): 498-505, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37955424
3.
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.
Blood
; 117(11): 3016-24, 2011 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21245487
4.
Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.
Blood
; 118(8): 2085-93, 2011 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21670470
5.
Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia.
Blood
; 118(13): 3489-98, 2011 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-21725050
6.
Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 29(14): 2593-2601, 2023 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37282671
7.
Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study.
J Clin Oncol
; 39(34): 3853-3865, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618601
8.
Phase II study of lenalidomide and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemia.
J Clin Oncol
; 31(5): 584-91, 2013 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23270003
9.
What is the best frontline therapy for patients with CLL and 17p deletion?
Curr Hematol Malig Rep
; 6(1): 36-46, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21153774
10.
Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia.
Leuk Lymphoma
; 56(12): 3452-4, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25926060